Literature DB >> 26748743

Mutational spectrum of Korean patients with corneal dystrophy.

H Chae1,2, M Kim1,2, Y Kim1,2, J Kim2, A Kwon2, H Choi2, J Park1,2, W Jang2, Y S Lee3, S H Park4, M S Kim4.   

Abstract

Corneal dystrophy typically refers to a group of rare hereditary disorders with a heterogeneous genetic background. A comprehensive molecular genetic analysis was performed to characterize the genetic spectrum of corneal dystrophies in Korean patients. Patients with various corneal dystrophies underwent thorough ophthalmic examination, histopathologic examination, and Sanger sequencing. A total of 120 probands were included, with a mean age of 50 years (SD = 18 years) and 70% were female. A total of 26 mutations in five genes (14 clearly pathogenic and 12 likely pathogenic) were identified in 49 probands (41%). Epithelial-stromal TGFBI dystrophies, macular corneal dystrophy and Schnyder corneal dystrophy (SCD) showed 100% mutation detection rates, while endothelial corneal dystrophies showed lower detection rates of 3%. Twenty six non-duplicate mutations including eight novel mutations were identified and mutations associated with SCD were identified genetically for the first time in this population. This study provides a comprehensive characterization of the genetic aberrations in Korean patients and also highlights the diagnostic value of molecular genetic analysis in corneal dystrophies.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Fuchs endothelial corneal dystrophy; Korea; Schnyder corneal dystrophy; Thiel-Behnke corneal dystrophy; granular corneal dystrophy; lattice corneal dystrophy; macular corneal dystrophy; molecular genetic analysis; posterior polymorphous corneal dystrophy

Mesh:

Substances:

Year:  2016        PMID: 26748743     DOI: 10.1111/cge.12726

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  7 in total

1.  Transforming growth factor β induced mutation-associated phenotype in a Chinese family exhibiting lattice corneal dystrophy.

Authors:  Chao Qu; Man Yu; Xiaoxin Guo; Jing Li; Xiaoqi Liu; Yi Shi; Bo Gong
Journal:  Biomed Rep       Date:  2017-08-30

Review 2.  The Molecular Basis of Fuchs' Endothelial Corneal Dystrophy.

Authors:  Jie Zhang; Charles N J McGhee; Dipika V Patel
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

3.  Two mutations in the transforming growth factor beta-induced gene associated with familial Lattice corneal dystrophy.

Authors:  Wen-Ping Cao; Hai-Gang Yuan; Ping Liu; Xue Li; Qi Hu
Journal:  Int J Ophthalmol       Date:  2017-03-18       Impact factor: 1.779

4.  A Mutation in ZNF143 as a Novel Candidate Gene for Endothelial Corneal Dystrophy.

Authors:  Yonggoo Kim; Hye Jin You; Shin Hae Park; Man Soo Kim; Hyojin Chae; Joonhong Park; Dong Wook Jekarl; Jiyeon Kim; Ahlm Kwon; Hayoung Choi; Yeojae Kim; A Rome Paek; Ahwon Lee; Jung Min Kim; Seon Young Park; Yonghwan Kim; Keehyoung Joo; Jongsun Jung; So-Hyang Chung; Jee Won Mok; Myungshin Kim
Journal:  J Clin Med       Date:  2019-08-06       Impact factor: 4.241

5.  Identification of a Novel Missense KRT12 Mutation in a Vietnamese Family with Meesmann Corneal Dystrophy.

Authors:  Pham Ngoc Dong; Le Xuan Cung; Tran Khanh Sam; Do Thi Thuy Hang; Doug D Chung; Turad A Alkadi; Arjun Buckshey; Junwei Zhang; Alexa Kassels; Anthony J Aldave
Journal:  Case Rep Ophthalmol       Date:  2020-03-17

6.  Compound heterozygous mutations in TGFBI cause a severe phenotype of granular corneal dystrophy type 2.

Authors:  Ikhyun Jun; Yong Woo Ji; Seung-Il Choi; Bo Ram Lee; Ji Sang Min; Eung Kweon Kim
Journal:  Sci Rep       Date:  2021-03-26       Impact factor: 4.379

7.  Clinical diversity in patients with Schnyder corneal dystrophy-a novel and known UBIAD1 pathogenic variants.

Authors:  Anna Sarosiak; Monika Udziela; Aneta Ścieżyńska; Dominika Oziębło; Anna Wawrzynowska; Jacek P Szaflik; Monika Ołdak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-06       Impact factor: 3.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.